Literature DB >> 22683156

Endothelial nitric oxide synthase mediates the first and inducible nitric oxide synthase mediates the second window of desflurane-induced preconditioning.

Andreas Redel1, Jan Stumpner, Thorsten M Smul, Markus Lange, Virginija Jazbutyte, Douglas G Ridyard, Norbert Roewer, Franz Kehl.   

Abstract

OBJECTIVES: Nitric oxide synthases (NOSs) mediate the first window of anesthetic-induced preconditioning (APC). The authors tested the hypothesis that endothelial NOS (eNOS) mediates the first window and inducible NOS (iNOS) mediates the second window of APC.
DESIGN: Randomized, prospective, blinded laboratory investigation.
SETTING: Experimental laboratory. PARTICIPANTS: Mice.
INTERVENTIONS: Mice were subjected to a 45-minute coronary artery occlusion (CAO) and a 180-minute reperfusion. C57BL/6 mice received desflurane, 1.0 minimum alveolar concentration, for 30 minutes or 12, 24, 48, or 96 hours before CAO. In eNOS(-/-) and iNOS(-/-) mice, desflurane was given 30 minutes and 48 hours before CAO. In the control groups, no desflurane was administered. Myocardial infarct size (IS) was determined after staining with Evans blue and triphenyltetrazolium chloride.
MEASUREMENTS AND MAIN RESULTS: The second window of APC was detectable at 48 hours but not at 12, 24, and 96 hours after preconditioning. In the control groups, IS was not different among the wild-type (50 ± 10%), eNOS(-/-) (52 ± 14%), and iNOS(-/-) (46 ± 10%) mice. The IS decreased significantly (p < 0.05) when desflurane was administered 30 minutes (10 ± 6%) or 48 hours (16 ± 7%) before CAO in wild-type mice, 48 hours (21 ± 13%) before CAO in eNOS(-/-) mice, and 30 minutes (13 ± 6%) before CAO in iNOS(-/-) mice. Desflurane given 30 minutes before CAO in eNOS(-/-) mice (60 ± 10%) and 48 hours before CAO in iNOS(-/-) mice (48 ± 21%) did not decrease the IS significantly compared with controls.
CONCLUSIONS: Endothelial NOS and iNOS work independently to mediate the first and second windows of APC, respectively. Endothelial NOS is not necessary to trigger the second window of APC.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22683156     DOI: 10.1053/j.jvca.2012.04.015

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  6 in total

1.  Myocardial ischemic protection in natural mammalian hibernation.

Authors:  Lin Yan; Raymond K Kudej; Dorothy E Vatner; Stephen F Vatner
Journal:  Basic Res Cardiol       Date:  2015-01-23       Impact factor: 17.165

2.  Anesthetic and subanesthetic doses of isoflurane conditioning provides strong protection against delayed cerebral ischemia in a mouse model of subarachnoid hemorrhage.

Authors:  Umeshkumar Athiraman; Meizi Liu; Keshav Jayaraman; Jane Yuan; Jogender Mehla; Gregory J Zipfel
Journal:  Brain Res       Date:  2020-10-22       Impact factor: 3.252

3.  S-nitrosation of mitochondrial connexin 43 regulates mitochondrial function.

Authors:  Daniel Soetkamp; Tiffany T Nguyen; Sara Menazza; Christine Hirschhäuser; Ulrike B Hendgen-Cotta; Tienush Rassaf; Klaus D Schlüter; Kerstin Boengler; Elizabeth Murphy; Rainer Schulz
Journal:  Basic Res Cardiol       Date:  2014-08-13       Impact factor: 17.165

4.  Remote and Anesthetic-Induced Myocardial Preconditioning Is Preserved in Atherosclerotic LDL Receptor-/- Mice In Vivo.

Authors:  Walter Petermichl; Kathrin Eglmeier; Henriette Hesse; Michael Gruber; Bernhard Graf; Andre Bredthauer; Andreas Redel
Journal:  Cardiovasc Ther       Date:  2021-05-24       Impact factor: 3.023

Review 5.  Peri-operative anaesthetic myocardial preconditioning and protection - cellular mechanisms and clinical relevance in cardiac anaesthesia.

Authors:  G Kunst; A A Klein
Journal:  Anaesthesia       Date:  2015-04       Impact factor: 6.955

6.  Argon Induces Protective Effects in Cardiomyocytes during the Second Window of Preconditioning.

Authors:  Britta Mayer; Josefin Soppert; Sandra Kraemer; Sabrina Schemmel; Christian Beckers; Christian Bleilevens; Rolf Rossaint; Mark Coburn; Andreas Goetzenich; Christian Stoppe
Journal:  Int J Mol Sci       Date:  2016-07-19       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.